P

Prism Biotech

Prelaunch prescriber profiling and targeting

Pharmaceutical Sales Representative - Entry/Specialty

Full-Time
$92.3k - $126.3k/yr
Mid
Greenville, SC, USA
In Person
Sales & Account ManagementField Sales

About the job

Requirements
  • Some college and/or sales experience is sought.
  • Proven customer acumen and relationship-building skills in a healthcare environment.
  • Experience interfacing with internal team members and external customers as part of a solution-based sales process.
  • Strong written and verbal communication and the ability to synthesize complex issues into simple messages.
  • Process orientation, resource management and allocation experience, and the ability to perform multiple tasks simultaneously.
  • Education and some knowledge of the healthcare or pharmaceutical industry and marketplace trends.
Responsibilities
  • Drive profitable sales growth by developing, maintaining, and advancing accounts through regular contact with medical offices, hospitals, and rehabilitation institutions within a defined territory.
  • Provide healthcare product demonstrations, physician detailing, and product in-servicing to current and potential customers.
  • Consult with physicians, nursing staff, phlebotomists, and medical office staff to secure product orders and increase product usage.
  • Sustain or generate new or repeat orders for products and programs.
  • Complete required reports accurately, completely, and in a timely manner to support effective business operations.
  • Perform other duties related to the position.
Desired Qualifications
  • Exceptional customer service, presentation, and communication skills.
  • Previous success attaining and exceeding sales goals.
  • Proficiency in Microsoft Office products, including Word, Excel, and PowerPoint.
  • Knowledge of contact management software.

About the company

Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Merion Township, Pennsylvania

Founded

2019

Get referred to Prism Biotech

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ono paid PRISM a milestone in November 2025, validating PepMetics execution.
  • E7386 Phase 1 results were published in January 2026, extending clinical credibility.
  • March 2026 Receptor.AI deal adds AI-driven discovery leverage for difficult targets.

What critics are saying

  • August 2026 nine-month loss widened to ¥845.7 million; burn remains heavy.
  • Servier terminated its collaboration in October 2025, proving partner churn hits PRISM.
  • September 2026 cash burn and no guidance set up a dilutive 2027 financing crunch.

What makes Prism Biotech unique

  • PepMetics targets intracellular protein-protein interactions, a hard, scarce drug-discovery niche.
  • PRISM BioLab monetizes by out-licensing programs to Eisai, Ono, and Servier.
  • 2026 collaborations with Receptor.AI and Talus deepen platform optionality.

Help us improve and share your feedback! Did you find this helpful?